Khosla Ventures
Listed as “Excelsior Sciences”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Excelsior Sciences develops chemistry suited to automation.
Its Blocc chemistry uses a modular and iterative approach to small-molecule work, with the company initially focusing on applications in medicines.
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Excelsior Sciences”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.